Cargando…

Association between hospital volume and in‐hospital mortality following radiofrequency ablation for hepatocellular carcinoma

BACKGROUND: Radiofrequency ablation (RFA) is a minimally invasive treatment for hepatocellular carcinoma (HCC). There is increasing evidence of an association between increasing hospital volume and lower postoperative mortality for many surgical procedures, but this is difficult to establish with mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, M., Tateishi, R., Yasunaga, H., Matsui, H., Fushimi, K., Ikeda, H., Yatomi, Y., Koike, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989986/ https://www.ncbi.nlm.nih.gov/pubmed/29951606 http://dx.doi.org/10.1002/bjs5.9

Ejemplares similares

In-hospital mortality associated with transcatheter arterial embolization for treatment of hepatocellular carcinoma in patients on hemodialysis for end stage renal disease: a matched-pair cohort study using a nationwide database
por: Sato, Masaya, et al.
Publicado: (2019)

Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
por: Shiina, Shuichiro, et al.
Publicado: (2012)

Surgical Resection or Radiofrequency Ablation for Small Hepatocellular Carcinoma
por: Kawaguchi, Yoshikuni, et al.
Publicado: (2023)

Frequency of and Predictive Factors for Vascular Invasion after Radiofrequency Ablation for Hepatocellular Carcinoma
por: Asaoka, Yoshinari, et al.
Publicado: (2014)

Variation in Risk-Standardized Mortality of Stroke among Hospitals in Japan
por: Matsui, Hiroki, et al.
Publicado: (2015)

Frequency, Risk Factors and Survival Associated with an Intrasubsegmental Recurrence after Radiofrequency Ablation for Hepatocellular Carcinoma
por: Tateishi, Ryosuke, et al.
Publicado: (2013)

Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation
por: Uchino, Koji, et al.
Publicado: (2018)

Features of extrahepatic metastasis after radiofrequency ablation for hepatocellular carcinoma
por: Yoon, Jae H, et al.
Publicado: (2020)

Development of Deep Learning Models for Predicting In-Hospital Mortality Using an Administrative Claims Database: Retrospective Cohort Study
por: Matsui, Hiroki, et al.
Publicado: (2022)

Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma
por: Kwak, Min Hwan, et al.
Publicado: (2022)

Radiofrequency Thermal Ablation of Hepatocellular Carcinomas
por: Lim, Hyo Keun
Publicado: (2000)

Machine-learning Approach for the Development of a Novel Predictive Model for the Diagnosis of Hepatocellular Carcinoma
por: Sato, Masaya, et al.
Publicado: (2019)

In-hospital mortality and successful weaning from venoarterial extracorporeal membrane oxygenation: analysis of 5,263 patients using a national inpatient database in Japan
por: Aso, Shotaro, et al.
Publicado: (2016)

Management of Spontaneously Ruptured Hepatocellular Carcinomas in the Radiofrequency Ablation Era
por: Cheung, Tan To, et al.
Publicado: (2014)

Role of radiofrequency ablation in unresectable hepatocellular carcinoma: An Indian experience
por: Kalra, Naveen, et al.
Publicado: (2013)

Proton Beam Therapy versus Radiofrequency Ablation for Patients with Treatment-Naïve Single Hepatocellular Carcinoma: A Propensity Score Analysis
por: Sekino, Yuta, et al.
Publicado: (2022)

Alteration of laboratory findings after radiofrequency ablation of hepatocellular carcinoma: relationship to severity of the underlying liver disease and the ablation volume
por: Shin, Sang-Wook, et al.
Publicado: (2015)

Sarcopenia as a Predictive Factor for Recurrence of Hepatocellular Carcinoma Following Radiofrequency Ablation
por: Jaruvongvanich, Varin, et al.
Publicado: (2023)

Factors affecting in-hospital mortality of non-tuberculous mycobacterial pulmonary disease
por: Tanaka, Goh, et al.
Publicado: (2021)

Use of radiofrequency ablation in the treatment of hepatocellular carcinoma: Experience of ablation protocols
por: MASAYOSHI, TAKAHASHI, et al.
Publicado: (2012)

Neoadjuvant Use of Oncolytic Herpes Virus G47Δ Enhances the Antitumor Efficacy of Radiofrequency Ablation
por: Yamada, Tomoharu, et al.
Publicado: (2020)

Radiofrequency Ablation of Hepatocellular Carcinoma: A Literature Review
por: Minami, Yasunori, et al.
Publicado: (2011)

Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma
por: Himoto, Takashi, et al.
Publicado: (2012)

An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation
por: Guo, Yusheng, et al.
Publicado: (2022)

Surgical Resection or Radiofrequency Ablation for Small Hepatocellular Carcinoma
por: Feng, Qingbo, et al.
Publicado: (2022)

Infectious complications related to radiofrequency ablation of liver tumors: The role of antibiotics
por: Nakagomi, Ryo, et al.
Publicado: (2021)

Percutaneous radiofrequency ablation for the treatment of hepatocellular carcinoma: long-term follow up, efficacy and prognostic factors
por: Filippiadis, Dimitrios K., et al.
Publicado: (2013)

Radiofrequency ablation of hepatocellular carcinomas: A new spectrum of anesthetic experience at a tertiary care hospital in Pakistan
por: Shamim, Faisal, et al.
Publicado: (2017)

Radiofrequency ablation of surface v/s intraparenchymal hepatocellular carcinoma in cirrhotic patients
por: Patidar, Yashwant, et al.
Publicado: (2017)

Treatment and outcome of hepatorenal syndrome in Japan: a retrospective cohort study using a national inpatient database
por: Okushin, Kazuya, et al.
Publicado: (2023)

A case of hemocholecyst associated with hemobilia following radiofrequency ablation therapy for hepatocellular carcinoma
por: Shin, Keun Young, et al.
Publicado: (2011)

Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma
por: Hao, Yoshiteru, et al.
Publicado: (2017)

Cost-Effectiveness Analysis of Follow-Up Schedule for Hepatocellular Carcinoma after Radiofrequency Ablation
por: Hu, Shuifang, et al.
Publicado: (2022)

The role of hepatic reserve in the mortality of cirrhotic patients with small hepatocellular carcinoma receiving radiofrequency ablation
por: Hung, Tsung-Hsing, et al.
Publicado: (2022)

Therapeutic Efficacy of Percutaneous Radiofrequency Ablation versus Microwave Ablation for Hepatocellular Carcinoma
por: Zhang, Lei, et al.
Publicado: (2013)

Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma
por: Xu, Yun, et al.
Publicado: (2017)

Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD
por: Yamauchi, Yasuhiro, et al.
Publicado: (2016)

EUS-guided radiofrequency ablation of a hepatocellular carcinoma of the liver
por: Attili, Fabia, et al.
Publicado: (2018)

Aggressive tumor recurrence after radiofrequency ablation for hepatocellular carcinoma
por: Kang, Tae Wook, et al.
Publicado: (2017)

Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma
por: Duan, Feng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rsdfttj9s8m4ehkb7osbio488j